Related Experiment Video
Updated: Aug 8, 2026

Vasodilation of Isolated Vessels and the Isolation of the Extracellular Matrix of Tight-skin Mice
Published on: March 24, 2017
D609, a phosphatidylcholine-specific phospholipase C inhibitor, blocks interleukin-1 beta-induced vascular cell
R R Cobb1, K A Felts, G C Parry
1Biology Department, Tanabe Research Laboratories, San Diego, California 92121, USA.
Insights
Phosphatidylcholine-specific phospholipase C is crucial for activating nuclear factor-kappa B and inducing vascular cell adhesion molecule 1 (VCAM-1) gene expression in endothelial cells during inflammation.
Area of Science:
- Immunology
- Cell Biology
- Molecular Biology
Background:
- Endothelial cells regulate leukocyte recruitment during inflammation.
- Cytokine induction of cell surface adhesion molecules, like vascular cell adhesion molecule 1 (VCAM-1), is a key mechanism.
Purpose of the Study:
- To investigate the role of phosphatidylcholine-specific phospholipase C in interleukin-1 beta-induced VCAM-1 gene expression.
- To determine if inhibiting phosphatidylcholine-specific phospholipase C affects VCAM-1 expression and its regulatory pathways.
Main Methods:
- Utilized D609, a phosphatidylcholine-specific phospholipase C inhibitor, in human endothelial cells.
- Assessed VCAM-1 cell surface expression and VCAM-1 promoter activity.
- Examined nuclear translocation and transcriptional activity of nuclear factor-kappa B.
Main Results:
- D609 significantly reduced VCAM-1 cell surface expression and promoter activity in a dose-dependent manner.
- D609 did not impede nuclear factor-kappa B nuclear translocation.
- D609 inhibited nuclear factor-kappa B-mediated transcription, indicating a role downstream of translocation.
Conclusions:
- Phosphatidylcholine-specific phospholipase C is essential for the activation of nuclear factor-kappa B signaling.
- This enzyme is required for cytokine-induced VCAM-1 gene expression in endothelial cells.
- Targeting phosphatidylcholine-specific phospholipase C may offer a strategy to modulate inflammatory responses.
Abstract:
At sites of inflammation, endothelial cells play a major role in defining the types of leukocytes that are recruited to a specific area. This is accomplished, at least in part, through the cytokine induction of cell surface adhesion molecules, including vascular cell adhesion molecule 1 (VCAM-1). We investigated the role of phosphatidylcholine-specific phospholipase C in the induction of VCAM-1 gene expression by interleukin-1 beta. D609, a phosphatidylcholine-specific phospholipase C inhibitor, reduced VCAM-1 cell surface expression and VCAM-1 promoter activity in human endothelial cells in a dose-dependent manner. D609 did not affect nuclear translocation of nuclear factor-kappa B but inhibited nuclear factor-kappa B-mediated transcription. The results of this study indicate that phosphatidylcholine-specific phospholipase C is required for activation of nuclear factor-kappa B and cytokine induction of VCAM-1 gene expression in endothelial cells.
More Related Videos
08:49Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
Published on: January 22, 2019
10:31A Liposome Membrane Permeability Assay for Investigating the Effects of Phosphatidylinositol Phosphate Groups on Membranotropic Action of Venom PLA2
Published on: September 26, 2025
Related Concept Videos
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
The JAK-STAT Signaling Pathway
TGF - β Signaling Pathway
IP3/DAG Signaling Pathway
Intracellular Signaling Affects Focal Adhesions
Some...